Bank of New York Mellon’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-133,230
Closed -$304K 4167
2024
Q2
$304K Buy
+133,230
New +$304K ﹤0.01% 3804
2024
Q1
Sell
-17,607
Closed -$53.7K 4331
2023
Q4
$53.7K Hold
17,607
﹤0.01% 4149
2023
Q3
$25.4K Hold
17,607
﹤0.01% 4221
2023
Q2
$43.8K Sell
17,607
-1,687
-9% -$4.2K ﹤0.01% 4186
2023
Q1
$51.7K Hold
19,294
﹤0.01% 4189
2022
Q4
$105K Sell
19,294
-203
-1% -$1.1K ﹤0.01% 4105
2022
Q3
$243K Buy
19,497
+3,872
+25% +$48.3K ﹤0.01% 3932
2022
Q2
$77K Sell
15,625
-114,645
-88% -$565K ﹤0.01% 4283
2022
Q1
$990K Buy
130,270
+301
+0.2% +$2.29K ﹤0.01% 3327
2021
Q4
$1.33M Buy
129,969
+4,719
+4% +$48.2K ﹤0.01% 3222
2021
Q3
$1.68M Buy
125,250
+10,424
+9% +$140K ﹤0.01% 3092
2021
Q2
$2.52M Sell
114,826
-15,941
-12% -$350K ﹤0.01% 2846
2021
Q1
$3.15M Sell
130,767
-768
-0.6% -$18.5K ﹤0.01% 2663
2020
Q4
$2.37M Sell
131,535
-8,680
-6% -$156K ﹤0.01% 2745
2020
Q3
$1.62M Sell
140,215
-806
-0.6% -$9.31K ﹤0.01% 2792
2020
Q2
$3.42M Buy
141,021
+7,295
+5% +$177K ﹤0.01% 2400
2020
Q1
$1.47M Sell
133,726
-575
-0.4% -$6.33K ﹤0.01% 2713
2019
Q4
$3.55M Buy
134,301
+2,024
+2% +$53.5K ﹤0.01% 2511
2019
Q3
$3.01M Sell
132,277
-2,867
-2% -$65.3K ﹤0.01% 2529
2019
Q2
$4.14M Sell
135,144
-979,181
-88% -$30M ﹤0.01% 2421
2019
Q1
$18.5M Buy
1,114,325
+27,415
+3% +$455K 0.01% 1592
2018
Q4
$20.8M Sell
1,086,910
-178,972
-14% -$3.43M 0.01% 1447
2018
Q3
$66.2M Buy
1,265,882
+2,891
+0.2% +$151K 0.02% 837
2018
Q2
$54.9M Buy
1,262,991
+1,183,940
+1,498% +$51.5M 0.01% 941
2018
Q1
$2.93M Buy
79,051
+49,710
+169% +$1.84M ﹤0.01% 2615
2017
Q4
$582K Buy
29,341
+6,483
+28% +$129K ﹤0.01% 3542
2017
Q3
$568K Buy
+22,858
New +$568K ﹤0.01% 3525